• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCN1 促进非酒精性脂肪性肝炎中的肝脂肪变性和炎症。

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis.

机构信息

Nantong Institute of Liver Disease, Department of Gastroenterology and Hepatology, Nantong Third People's Hospital, Nantong University, Nantong, Jiangsu, China.

Department of Neurology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.

出版信息

Sci Rep. 2020 Feb 21;10(1):3201. doi: 10.1038/s41598-020-60138-8.

DOI:10.1038/s41598-020-60138-8
PMID:32081971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7035350/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is characterized by increased uptake and accumulation of lipids in hepatocytes. Simple steatosis may progress to non-alcoholic steatohepatitis (NASH) with inflammation, hepatocellular injury and fibrosis. CCN1 is an important matrix protein that regulates cell death and promotes immune cell adhesion and may potentially control this process. The role of CCN1 in NASH remains unclear. We investigated the role of CCN1 in the pathogenesis of steatohepatitis. CCN1 upregulation was found to be closely related with steatosis in patients with NASH, obese mice and a FFA-treated hepatocyte model. Controlling the expression of CCN1 in murine NASH models demonstrated that CCN1 increased the severity of steatosis and inflammation. From the sequence results, we found that fatty acid metabolism genes were primarily involved in the MCD mice overexpressing CCN1 compared to the control. Then, the expression of fatty acid metabolism genes was determined using a custom-designed pathway-focused qPCR-based gene expression array. Expression analysis showed that CCN1 overexpression significantly upregulated the expression of fatty acid metabolism-associated genes. In vitro analysis revealed that CCN1 increased the intracellular TG content, the pro-inflammatory cytokines and the expression level of apoptosis-associated proteins in a steatosis model using murine primary hepatocytes. We identified CCN1 as an important positive regulator in NASH.

摘要

非酒精性脂肪性肝病(NAFLD)的特征是肝细胞内脂质摄取和积聚增加。单纯性脂肪变性可能进展为伴有炎症、肝细胞损伤和纤维化的非酒精性脂肪性肝炎(NASH)。CCN1 是一种重要的基质蛋白,可调节细胞死亡并促进免疫细胞黏附,可能潜在地控制这一过程。CCN1 在 NASH 中的作用尚不清楚。我们研究了 CCN1 在脂肪性肝炎发病机制中的作用。发现 CCN1 的上调与 NASH 患者、肥胖小鼠和 FFA 处理的肝细胞模型中的脂肪变性密切相关。在小鼠 NASH 模型中控制 CCN1 的表达表明,CCN1 增加了脂肪变性和炎症的严重程度。从序列结果来看,我们发现与对照相比,在过表达 CCN1 的 MCD 小鼠中,脂肪酸代谢基因主要参与。然后,使用定制的基于通路的 qPCR 基因表达谱芯片检测脂肪酸代谢基因的表达。表达分析表明,CCN1 过表达显著上调了脂肪酸代谢相关基因的表达。体外分析显示,CCN1 在脂肪变性模型中增加了小鼠原代肝细胞中的细胞内 TG 含量、促炎细胞因子和凋亡相关蛋白的表达水平。我们确定 CCN1 是非酒精性脂肪性肝炎(NASH)的一个重要正向调节因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/b5aca970f588/41598_2020_60138_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/8123a488d1fb/41598_2020_60138_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/878a09ea6069/41598_2020_60138_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/b2fffb9d4910/41598_2020_60138_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/0aa83e61d7ea/41598_2020_60138_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/9b077cdc0295/41598_2020_60138_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/fa98fbc77074/41598_2020_60138_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/cb1aacfbcbc2/41598_2020_60138_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/c1548efa524e/41598_2020_60138_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/b5aca970f588/41598_2020_60138_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/8123a488d1fb/41598_2020_60138_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/878a09ea6069/41598_2020_60138_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/b2fffb9d4910/41598_2020_60138_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/0aa83e61d7ea/41598_2020_60138_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/9b077cdc0295/41598_2020_60138_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/fa98fbc77074/41598_2020_60138_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/cb1aacfbcbc2/41598_2020_60138_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/c1548efa524e/41598_2020_60138_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e28/7035350/b5aca970f588/41598_2020_60138_Fig9_HTML.jpg

相似文献

1
CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis.CCN1 促进非酒精性脂肪性肝炎中的肝脂肪变性和炎症。
Sci Rep. 2020 Feb 21;10(1):3201. doi: 10.1038/s41598-020-60138-8.
2
CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice.CCN1 在肝细胞中的表达有助于促进小鼠非酒精性脂肪性肝病中的巨噬细胞浸润。
J Lipid Res. 2013 Jan;54(1):44-54. doi: 10.1194/jlr.M026013. Epub 2012 Oct 15.
3
Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.G 蛋白偶联受体激酶 2(GRK2)在小鼠和人类非酒精性脂肪性肝病和脂肪性肝炎发生发展中的作用。
Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3655-3667. doi: 10.1016/j.bbadis.2018.09.027. Epub 2018 Sep 24.
4
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.Gasdermin D 在人类和小鼠的非酒精性脂肪性肝炎中作为细胞焦亡的效应蛋白发挥关键作用。
J Hepatol. 2018 Apr;68(4):773-782. doi: 10.1016/j.jhep.2017.11.040. Epub 2017 Dec 20.
5
CD44 is a key player in non-alcoholic steatohepatitis.CD44 是非酒精性脂肪性肝炎的关键参与者。
J Hepatol. 2017 Aug;67(2):328-338. doi: 10.1016/j.jhep.2017.03.003. Epub 2017 Mar 16.
6
CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.CXCL10 作为一种炎症介质和非酒精性脂肪性肝炎的非侵入性生物标志物发挥着关键作用。
J Hepatol. 2014 Dec;61(6):1365-75. doi: 10.1016/j.jhep.2014.07.006. Epub 2014 Jul 15.
7
CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.CD36 的棕榈酰化作用破坏游离脂肪酸代谢并促进非酒精性脂肪性肝炎中的组织炎症。
J Hepatol. 2018 Sep;69(3):705-717. doi: 10.1016/j.jhep.2018.04.006. Epub 2018 Apr 27.
8
Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.肝脏丙氨酸可将人类和小鼠的非酒精性脂肪性肝炎与单纯性脂肪变性区分开来:质子磁共振波谱研究与长回波时间。
J Magn Reson Imaging. 2017 Nov;46(5):1298-1310. doi: 10.1002/jmri.25673. Epub 2017 Feb 22.
9
Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.白细胞介素-17 加剧非酒精性脂肪性肝病中的肝脂肪变性和炎症。
Clin Exp Immunol. 2011 Nov;166(2):281-90. doi: 10.1111/j.1365-2249.2011.04471.x.
10
The role of hepassocin in the development of non-alcoholic fatty liver disease.海帕西菌素在非酒精性脂肪性肝病发展中的作用。
J Hepatol. 2013 Nov;59(5):1065-72. doi: 10.1016/j.jhep.2013.06.004. Epub 2013 Jun 18.

引用本文的文献

1
Cysteine-rich 61 inhibition attenuates hepatic insulin resistance and improves lipid metabolism in high-fat diet fed mice and HepG2 cells.富含半胱氨酸的 61 抑制物可减轻高脂饮食喂养的小鼠和 HepG2 细胞的肝胰岛素抵抗并改善脂代谢。
FASEB J. 2024 Aug 15;38(15):e23859. doi: 10.1096/fj.202400860R.
2
Matricellular proteins in immunometabolism and tissue homeostasis.细胞基质蛋白在免疫代谢和组织动态平衡中的作用。
BMB Rep. 2024 Sep;57(9):400-416. doi: 10.5483/BMBRep.2023-0156.
3
CCN3/NOV Serum Levels in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients in Comparison with the Healthy Group and their Correlation with TNF-α and IL-6.

本文引用的文献

1
Molecular pathways of nonalcoholic fatty liver disease development and progression.非酒精性脂肪性肝病发生和进展的分子途径。
Cell Mol Life Sci. 2019 Jan;76(1):99-128. doi: 10.1007/s00018-018-2947-0. Epub 2018 Oct 20.
2
Non-alcoholic fatty liver disease: an update on diagnosis.非酒精性脂肪性肝病:诊断的最新进展
Clujul Med. 2018;91(2):147-150. doi: 10.15386/cjmed-993. Epub 2018 Apr 25.
3
Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.油酸可保护肝细胞及非酒精性脂肪性肝炎大鼠中饱和脂肪酸介导的脂毒性。
非酒精性脂肪性肝病(NAFLD)患者与健康组相比的CCN3/NOV血清水平及其与TNF-α和IL-6的相关性
Curr Mol Med. 2024 Feb 23. doi: 10.2174/0115665240285539240214111947.
4
The Janus-Faced Role of Lipid Droplets in Aging: Insights from the Cellular Perspective.脂滴在衰老中的双面角色:来自细胞视角的见解。
Biomolecules. 2023 May 30;13(6):912. doi: 10.3390/biom13060912.
5
Recent progress on the role of cellular communication network factors (CCN) 3, 4 and 6 in regulating adiposity, liver fibrosis and pancreatic islets.细胞通讯网络因子(CCN)3、4和6在调节肥胖、肝纤维化及胰岛方面作用的最新进展
J Cell Commun Signal. 2023 Jun;17(2):297-306. doi: 10.1007/s12079-023-00765-8. Epub 2023 May 28.
6
CCN proteins: opportunities for clinical studies-a personal perspective.CCN蛋白:临床研究的机遇——个人观点
J Cell Commun Signal. 2023 Jun;17(2):333-352. doi: 10.1007/s12079-023-00761-y. Epub 2023 May 17.
7
CCN1/Integrin αβ Instigates Free Fatty Acid-Induced Hepatocyte Lipid Accumulation and Pyroptosis through NLRP3 Inflammasome Activation.CCN1/整合素 αβ 通过 NLRP3 炎性体激活引发游离脂肪酸诱导的肝细胞脂质积累和细胞焦亡。
Nutrients. 2022 Sep 19;14(18):3871. doi: 10.3390/nu14183871.
8
The Anti-Tumor Efficacy of Verbascoside on Ovarian Cancer Facilitating CCN1-AKT/NF-κB Pathway-Mediated M1 Macrophage Polarization.毛蕊花糖苷对卵巢癌的抗肿瘤作用:促进CCN1-AKT/NF-κB信号通路介导的M1巨噬细胞极化
Front Oncol. 2022 Jun 17;12:901922. doi: 10.3389/fonc.2022.901922. eCollection 2022.
9
Extracellular vesicles: mediators of intercellular communication in tissue injury and disease.细胞外囊泡:组织损伤和疾病中细胞间通讯的介导者。
Cell Commun Signal. 2021 Oct 16;19(1):104. doi: 10.1186/s12964-021-00787-y.
10
CYR61, regulated by miR-22-3p and MALAT1, promotes autophagy in HK-2 cell inflammatory model.由miR-22-3p和MALAT1调控的CYR61在HK-2细胞炎症模型中促进自噬。
Transl Androl Urol. 2021 Aug;10(8):3486-3500. doi: 10.21037/tau-21-623.
Life Sci. 2018 Jun 15;203:291-304. doi: 10.1016/j.lfs.2018.04.022. Epub 2018 Apr 27.
4
Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China.中国乌鲁木齐社区居民非酒精性脂肪性肝病的危险因素及社区干预
Medicine (Baltimore). 2018 Mar;97(9):e0021. doi: 10.1097/MD.0000000000010021.
5
The concept of the CCN protein family revisited: a centralized coordination network.CCN蛋白家族概念再探讨:一个集中协调网络
J Cell Commun Signal. 2018 Mar;12(1):3-12. doi: 10.1007/s12079-018-0455-5. Epub 2018 Feb 22.
6
The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells.基质细胞蛋白CCN6(WISP3)可降低Notch1水平并抑制乳腺癌起始细胞。
Oncotarget. 2016 May 3;7(18):25180-93. doi: 10.18632/oncotarget.7734.
7
Pathogenesis of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的发病机制
Cell Mol Life Sci. 2016 May;73(10):1969-87. doi: 10.1007/s00018-016-2161-x. Epub 2016 Feb 19.
8
Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).CCN家族蛋白在肿瘤发生和癌症转移中的新作用(综述)
Int J Mol Med. 2015 Dec;36(6):1451-63. doi: 10.3892/ijmm.2015.2390. Epub 2015 Oct 23.
9
Matricellular proteins of the Cyr61/CTGF/NOV (CCN) family and the nervous system.Cyr61/CTGF/NOV(CCN)家族的基质细胞蛋白与神经系统
Front Cell Neurosci. 2015 Jun 24;9:237. doi: 10.3389/fncel.2015.00237. eCollection 2015.
10
ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease.在非酒精性脂肪性肝病的细胞和小鼠模型中,ASPP2通过减少自噬来降低甘油三酯,从而保护肝细胞免受损伤。
J Cell Mol Med. 2015 Jan;19(1):155-64. doi: 10.1111/jcmm.12364. Epub 2014 Sep 25.